raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:411602

Hereditary late-onset Parkinson disease

Synonyms: Autosomal dominant late-onset Parkinson disease · LOPD

Type
Disease
Group
Disorder
Inheritance
Autosomal dominant
Age of onset
Adult, Elderly
Status
active

Hereditary late-onset Parkinson disease (LOPD) is a form of Parkinson disease (PD), characterized by an age of onset of more than 50 years, tremor at rest, gait complaints and falls, bradykinesia, rigidity and painful cramps. Patients usually present a low risk of developing non motor symptoms, dystonia, dyskinesia and levodopa-induced dyskinesia (LID).

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enHereditary late-onset Parkinson diseaseAutosomal dominant late-onset Parkinson disease · LOPD
frMaladie de Parkinson héréditaire à début tardifLOPD · Maladie de Parkinson autosomal dominant à début tardif
deHereditäre Parkinson-Krankheit mit spätem BeginnAutosomal-dominante spät-beginnende Parkinson-Krankheit · LOPD
esEnfermedad de Parkinson hereditaria de inicio tardíoEnfermedad de Parkinson de inicio tardío autosómica dominante · LOPD
itMalattia ereditaria di Parkison a esordio tardivoLOPD · Malattia di Parkinson a esordio tardivo autosomica dominante
nlErfelijke ziekte van Parkinson met late aanvangAutosomaal dominante ziekte van Parkinson met late aanvang · LOPD
ptDoença de Parkinson hereditária com início tardio
plDziedziczna choroba Parkinsona o późnym początkuAutosomalna dominująca choroba Parkinsona o późnym początku · LOPD
csHereditární Parkinsonova nemoc s pozdním nástupemLOPD · Autozomálně dominantní Parkinsonova choroba s pozdním nástupem
ukСпадкова хвороба Паркінсона з пізнім початкомАутосомно-домінантна хвороба Паркінсона з пізнім початком · LOPD
zh遗传性迟发帕金森病常染色体显性遗传晚期起病帕金森病
trKalıtsal geç başlangıçlı Parkinson hastalığıLOPD · Otozomal dominant geç başlangıçlı Parkinson hastalığı

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM168601BTNTvalidated
OMIM605543BTNTvalidated
OMIM607060BTNTvalidated
OMIM607688BTNTvalidated
OMIM614203BTNTvalidated
OMIM614251BTNTvalidated
OMIM616361BTNTvalidated
ICD-10G20NTBTattributedvalidated
MONDO0008199Evalidated
MONDO8199Evalidated
UMLSC4274355Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (6):

No children.

4

Genes

7 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
EIF4G1Candidate gene tested inNot yet assessedHGNC:3296ENSG000001148676004953q27.1eukaryotic translation initiation factor 4 gamma 1
GIGYF2Candidate gene tested inNot yet assessedHGNC:11960ENSG000002041206120032q37.1GRB10 interacting GYF protein 2
DNAJC13Disease-causing germline mutation(s) (gain of function) inAssessedHGNC:30343ENSG000001382466143343q22.1DnaJ heat shock protein family (Hsp40) member C1324218364[PMID]
LRRK2Disease-causing germline mutation(s) (gain of function) inAssessedHGNC:18618ENSG0000018890660900712q12leucine rich repeat kinase 222166458[PMID]
SNCADisease-causing germline mutation(s) (gain of function) inAssessedHGNC:11138ENSG000001453351638904q22.1synuclein alpha17489854[PMID]_18704525[PMID]_20013014[PMID]_24768741[PMID]_17489854[PMID]_18704525[PMID]
VPS35Disease-causing germline mutation(s) inAssessedHGNC:13487ENSG0000006932960150116q11.2VPS35 retromer complex component22166458[PMID]
GBA1Major susceptibility factor inAssessedHGNC:4177ENSG000001776286064631q22glucosylceramidase beta 118987351[PMID]
5

Prevalence and incidence

1 record
TypeClassValueAreaQualificationValidationSource
Point prevalenceUnknown—WorldwideClass onlyValidated[EXPERT]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

34 annotations · validated 2018-06-13
HPOTerm (as annotated by Orphanet)Diagnostic
Obligate (100%)
HP:0001300Parkinsonism
Frequent (79-30%)
HP:0002304Akinesia
HP:0012450Chronic constipation
HP:0000651Diplopia
HP:0002015Dysphagia
HP:0002359Frequent falls
HP:0004409Hyposmia
HP:0002548Parkinsonism with favorable response to dopaminergic medication
HP:0002322Resting tremor
HP:0005340Spastic/hyperactive bladder
Occasional (29-5%)
HP:0000713Agitation
HP:0000741Apathy
HP:0002067Bradykinesia
HP:0002120Cerebral cortical atrophy
HP:0000716Depression
HP:0100660Dyskinesia
HP:0001332Dystonia
HP:0002171Gliosis
HP:0000338Hypomimic face
HP:0100710Impulsivity
HP:0100315Lewy bodies
HP:0000744Low frustration tolerance
HP:0001268Mental deterioration
HP:0031435Monotonic speech
HP:0003394Muscle spasm
HP:0004926Orthostatic hypotension due to autonomic dysfunction
HP:0002172Postural instability
HP:0002063Rigidity
HP:0002362Shuffling gait
HP:0002360Sleep abnormality
HP:0002367Visual hallucinations
HP:0001824Weight loss
Very rare (<4-1%)
HP:0000726Dementia
HP:0100753Schizophrenia

Run the differential on the 1 obligate / very frequent terms

Annotation source: 19524782[PMID]_17251522[PMID]_19632874[PMID]_15541308[PMID]_20457952[PMID]_22801713[PMID]_18342564[PMID]_21907011[PMID]_24218364[PMID]

7

Sources for this card